InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: Type0neg post# 47647

Thursday, 02/09/2017 7:10:00 PM

Thursday, February 09, 2017 7:10:00 PM

Post# of 203921
500 Million shares authorized, 140 Million issued. They will absolutely be issuing warrants and options after revenue starts pouring in. They don't have to disclose employment contracts, so who knows how much skin they actually have in the game.

Funny, reminds me of a private email I got last month. Person said, "aren't you worried that they only pay themselves 12K a year". Look at Company X, they pay themselves $250,000 a year each. To which I LOLed heartily.

That other company had so much toxic debt, over 1 Billion shares issued and so many other real red flags.

Do you think the two world-class additions to the Advisory Board joined for free? I'm sure their contacts include a ton of shares.

Yes, dilution is bad. But it's inevitable in any biotech company. Based on everything else OWCP does, my guess is the dilution will be conservative and the shareholders will be respected.

I also expect to see the salaries increase, but I think that is very well deserved.